SoftBank's Masayoshi Son bets on narcolepsy drug for sleep-deprived Japan

The proportion of people sleeping less than the recommended eight hours is rising globally, and costs Japan as much as $138 billion in economic losses each year, according to Rand Corp.

Related Keywords

Japan ,France ,French ,Japanese ,Bioprojet Pharma ,Masayoshi Son ,Catalys Pacific ,Kazunari Tsunaba ,Rand Corp ,Softbank Group Corp ,Japan Preventative Association Of Lifestyle ,Japan Aculys Pharma ,Softbank Vision Fund ,Wework Inc ,Softbank ,Vision Fund ,Sumitomo Mitsui Trust Investment ,Softbank Group ,Japan Preventative Association ,Global Founders Capital ,Investment Director Peter Park ,Startups ,Pharmaceuticals ,Mental Health ,Aculys Pharma ,